Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acamprosate calcium enteric-coated tablets pharmacokinetic and bioequivalence study in healthy Chinese male volunteers
ChiCTR-TTRCC-14004853Phase 4Not yet recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jul 2014
- Modality
- Small Interfering RNA (siRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, MicroRNA (miRNA) → Small RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics, Antisense Oligonucleotides (ASOs) → Long RNA Therapeutics → RNA Therapeutics → Nucleic Acid Therapeutics
- Countries
- 1
01
Overview
Phase 4, open-label trial of SNC-102 (2 arms), sponsored by West China Hospital of Sichuan University. Primary endpoint: Plasma drug concentration. Planned start Jul 2014; status: not yet recruiting.
02
Drugs
SNC-102
Beyond the preview
Go deeper on ChiCTR-TTRCC-14004853.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-TTRCC-14004853.